CALT Shares Outstanding History Table | ||||
Also see: CALT Market Cap History CALT YTD Return |
CALT Shares Outstanding History Table | ||||
Also see: CALT Market Cap History CALT YTD Return |
CALT Shares Outstanding History Chart | |||||
Mouse over chart for data details
|
CALT Stock Price Chart |
About Calliditas Therapeutics AB |
Calliditas Therapeutics is engaged in the development and commercial of its FDA-approved product, Nefecon (marketed in United States under the name TARPEYO), for patients with the autoimmune renal disease immunoglobulin A, or IgA, nephropathy, and a portfolio of product candidates. We show 1 historical shares outstanding datapoints in our coverage of CALT's shares outstanding history. Understanding the changing numbers of CALT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CALT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CALT by allowing them to research CALT shares outstanding history as well as any other stock in our coverage universe. |
CALT Current Stock Quote |
Free CALT Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
CALT Share Performance |
Shares Outstanding Peers |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.